Search
for
Sort by
Research 61–90 of 1000+
- Androgenetic alopecia; drug safety and therapeutic strategies
- <i>In vivo</i> and <i>in silico</i> evaluation of the ameliorative effect of hesperidin on finasteride-induced testicular oxidative stress in Wistar rats
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selective inhibitors of human 5α-reductase 1
- 5α-Reductase underscores the development of pectoral fin breeding tubercles in zebrafish
- Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice
- Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites
- In Vitro and In Vivo Regulation of SRD5A mRNA Expression of Supercritical Carbon Dioxide Extract from Asparagus racemosus Willd. Root as Anti-Sebum and Pore-Minimizing Active Ingredients
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Androgenic alopecia and dutasteride in hair mesotherapy: A short review
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Chapter 23. Therapeutic Control of Androgen Action
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Role of neurosteroids in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked neuronal injury and behavioral deficits in mice
- Hormone Blocking Anticancer Drugs
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- Managing patterned hair loss – a hair raising task!
- Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation
- Synergistic Phytochemical and Pharmacological Actions of Hair RiseTM Microemulsion: A Novel Herbal Formulation for Androgenetic Alopecia and Hair Growth Stimulation
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies